CO - Global Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD
2.6000
0.0000 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close2.6000
Open2.6000
Bid2.5900 x 2200
Ask2.6000 x 800
Day's Range2.5900 - 2.6100
52 Week Range2.5400 - 6.9800
Volume220,486
Avg. Volume140,771
Market Cap316.033M
Beta (5Y Monthly)0.38
PE Ratio (TTM)8.87
EPS (TTM)0.2930
Earnings DateMar 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 31, 2018
1y Target Est15.00
  • 10 Penny Stocks to Buy Under $5 That Might Be Worth the Risk
    InvestorPlace

    10 Penny Stocks to Buy Under $5 That Might Be Worth the Risk

    Back in September 2017, I picked seven beaten-down stocks to buy. I did so after reading a blog post from Ben Carlson, one of the best financial bloggers in the country. The problem with selecting beaten-down or penny stocks to buy is that they often come with a lot of baggage. Baggage that's not necessarily going to disappear overnight. "When dumpster diving for beaten-down shares, you must be able to understand how far divorced fundamentals have become from investor expectations," Carlson wrote in 2017. "While there were bargains galore in early 2009, late 2011 and even early 2016, if you want to find value in these markets, you have to go dumpster diving."InvestorPlace - Stock Market News, Stock Advice & Trading TipsWell, of the seven stocks on my list, only one, Kroger (NYSE:KR), is higher today than it was in September 2017. * 7 Red-Hot Vaccine Stocks Racing to Develop a Coronavirus Cure The glutton for punishment that I am, I've decided to go back to the dumpster to find 10 penny stocks to buy trading under $5 as I write this. Hopefully, I'll do a little better this time around. Penny Stocks to Buy: Banco BBVA Argentina (BBAR)Source: Shutterstock Market Cap: $765.9 million Price-to-Book: 0.62Banco Bbva Argentina (NYSE:BBAR), as its name suggests, is a financial services company based in Buenos Aires, Argentina. It has operated in Argentina since 1886. Its American Depositary Shares have been traded on the NYSE since 1993. It is the fourth-largest privately-owned bank in Argentina with 7.7% of the country's total banking system loans on a consolidated basis. At the end of 2019, it had 454 billion Argentine pesos in total assets on its balance sheet. Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) is a Spanish bank. It owns 66% of the Argentinian bank. Bank of New York Mellon (NYSE:BNY) is also a large shareholder with 18% of BBVA's stock.In 2019, it made 16 billion pesos on 88 billion pesos in revenue. That revenue is up significantly from 49 billion pesos in 2017. However, investing in Argentina is not for the faint of heart. The country is notoriously bad at defaulting on its debt, making investments extremely volatile. That said, BBAR is cheaper than it has been in the past five years. I would recommend the bank stock for aggressive investors only. Global Cord Blood Corp. (CO)Source: Shutterstock Market Cap: $323.3 million Price-to-Book: 0.61After what's happened to Luckin Coffee (NYSE:LK) in 2020, most investors will probably want to steer clear of Chinese investments, except maybe Alibaba (NYSE:BABA) and a handful of other stocks. For those more adventurous, Global Cord Blood (NYSE:CO) holds three out of the seven licenses to operate cord blood banks in China. Two million babies are born each year in the three markets it operates: Beijing, Guangdong and Zhejiang. It has accumulated over 815,000 subscribers since its founding in 2003. Globally, there are 35 private cord blood banks in the U.S., another 104 in Europe and 54 in South America. Approximately four million private cord blood units are stored worldwide. Global Blood Corp. has 47% market share in China. The company charges a one-time processing fee of 9,800 Chinese Yuan and an annual storage fee of 860 Chinese Yuan for 18 years. That translates to $200 per customer per year amortized over 18 years. It adds up. * 10 Stocks to Buy to Weather the Recession In the first nine months of 2020, the company had revenues of $132.4 million, 25.4% higher than a year earlier, along with operating income of $58.8 million, 39.9% higher than in the first nine months of fiscal 2019. Silvercorp Metals (SVM)Source: Shutterstock Market Cap: $688.4 million Price-to-Book: 1.88Vancouver-based Silvercorp Metals (NYSEAMERICAN:SVM) entered the Chinese market in 2004 by acquiring the Ying project, a small producing mine in the Henan province. Today, Silvercorp produces 6.4 million ounces of silver annually, 22.7 million pounds of zinc and more than 3,500 ounces of gold.On May 17, Silvercorp announced it would acquire Guyana Goldfields (OTCMKTS:GUYFF) for 227 million CAD in a cash-and-stock deal worth $1.30 per share. Guyana operates the Aurora gold mine in Guyana. The mine produces between 145,000 and 160,000 ounces per year. It has been in production since 2016. The acquisition creates a diversified precious metals producer that generates positive free cash flow. With Guyana Goldfields under its wing, it will have a strong balance sheet to make further acquisitions and move the Aurora mine from an open-pit operation to an underground mine with more than 14 years of production capacity. Newmark Group (NMRK)Source: Shutterstock Market Cap: $737.9 million Price-to-Book: 1.16Newmark (NASDAQ:NMRK) is a full-service commercial real estate advisory that provides services to both owners and tenants. The company was spun-off from its former parent, BGC Partners (NASDAQ:BGCP), in November 2018. On May 7, Newmark reported its Q1 2020 results. On the top line, it had $483.9 million in revenue, 8.1% higher than a year earlier. On the bottom line, it had adjusted earnings of $23.5 million, 57.8% lower than in the same period a year earlier. Sales were 2% lower than the consensus estimate while its GAAP profit was 3 cents per share, 70% lower than the consensus estimate. Since it announced earnings, its shares have basically gone sideways, which is a good sign if you've owned its shares for a long time. One thing dividend investors will notice is that the company cut its quarterly dividend by 90% from 10 cents to 1 cent starting with the June payment. With the dividend cut, it currently yields slightly less than 1%. * 7 Gun Stocks to Buy During the Coronavirus Pandemic Expect Newmark to face a tough commercial real estate market over the next few quarters. However, it has made several moves, including the dividend cut, to ensure it remains financially sound during the economic downturn caused by the novel coronavirus. Smith Micro Software (SMSI)Source: Shutterstock Market Cap: $173.6 million Price-to-Book: 3.28Smith Micro Software (NASDAQ:SMSI) provides software to wireless carriers to enhance their user experience. It currently has three main products: SafePath, CommSuite and ViewSpot. In the latest quarter ended March 31, SafePath generated 59% of the company's $13.2 million in wireless revenue during the quarter while CommSuite accounted for another 34%.SafePath's solutions keep families' devices connected providing a safer, more enjoyable digital experience. CommSuite provides voice-to-text voice mail messaging for mobile devices that can be accessed from anywhere using any device. It has been installed on more than 18 million mobile devices. In the first quarter, Smith Micro had adjusted net income of $4.1 million, up significantly from $776,000 a year earlier. The company continues to expand its product offerings beyond SafePath and CommSuite, providing investors with a diversified penny stock opportunity. One thing to be aware of before you invest: Sprint accounts for 88% of the company's total revenue. Its merger with T-Mobile (NASDAQ:TMUS) could affect the relationship in the future. Orion Energy Systems (OESX)Source: Shutterstock Market Cap: $138.3 million Price-to-Book: 4.40Orion Energy Systems (NASDAQ:OESX) manufactures indoor and outdoor LED lighting and lighting solutions for all kinds of different industries, including agriculture, healthcare, retail, etc. The company's lighting solutions are 100% turnkey, providing customers with just one touchpoint when it comes to service.Its customers are some of the biggest names including Costco (NASDAQ:COST), Coca-Cola (NYSE:KO) and General Electric (NYSE:GE).On March 16, Orion was added to the CIBC Atlas Clean Energy Index, an index with exposure to U.S. and Canadian companies operating in the clean energy sector. Segments include solar, wind, hydro, geothermal, electric vehicles, LED and many others. As of May 26, the index had a one-year return of 29.9%. In February, Orion reported Q3 2020 results that included revenue growth of 110%. More importantly, its net income went from a loss of $700,000 in Q3 2019 to a profit of $2.3 million. As a result of its strong showing in the third quarter, it upped its fiscal 2020 guidance from $140 million at the midpoint to $152.5 million at the midpoint. * 6 Companies to Invest in Today for 10 Years of Growth Orion is definitely an under-the-radar type of penny stock opportunity. Mistras Group (MG)Source: Shutterstock Market Cap: $127.9 million Price-to-Book: 0.75Mistras Group (NYSE:MG) proclaims it is the only publicly traded pure-play asset protection company in the U.S. with more than 115 locations worldwide managed by approximately 5,000 employees.Founded in 1978, the company originally known as Physical Acoustics Corporation, became Mistras Group in 2007. Two years later it completed its IPO. The company helps industries such as oil and gas keep their assets running safely. Oil and gas account for approximately 56% of its revenue with aerospace and defense (15%) and industrials (12%) helping carry some of the load. Mistras' core business involves the non-destructive testing (NDT) of assets, a market that's estimated to be $14 billion worldwide. It has an approximately 4.5% share of the global NDT market.In the near term, Covid-19 is causing delays in projects, especially in the oil and gas sector. As a result, it expects revenues to face declines in the second quarter, but that higher oil prices means the third and fourth quarters will likely see energy companies undertake testing projects they've postponed due to the pandemic and lower prices.Down almost 70% year to date, Mistras is worth taking a closer look at. Office Depot (ODP)Source: Jonathan Weiss / Shutterstock.com Market Cap: $1.3 billion Price-to-Book: 0.59Definitely the largest of the penny stocks to buy discussed so far, it's probably the best known as well. Who hasn't been to Office Depot (NASDAQ:ODP) at some point in their life? It's hard to believe ODP once traded over $40.While it's unlikely to get back to those lofty heights, aggressive investors ought to consider taking a flyer on this once-dominant office supplies retailer.Office Depot announced a restructuring plan on May 18 that includes closing stores, distribution centers and reducing its headcount by 13,100 people by the end of 2023. The company expects the restructuring to save it $860 million in the next three-and-a-half years. The company is moving to a business-to-business and IT services focus. The cuts will help it invest in growing these segments of its business. Unfortunately, Covid-19 is hurting this segment at a time when it can ill afford to lose momentum. Fortunately, its retail stores have been deemed essential services during the crisis, so sales at its stores rose by 2% during the first quarter. * The 9 Best Cheap Stocks to Fill Up On Now Over the past five years, Office Depot's price-to-book ratio averaged 1.17. Today, it's half that amount. I wouldn't buy this stock if you really need the money, but if you can afford to lose the entire amount, the risk/reward is quite balanced. Garrett Motion (GTX)Source: Shutterstock Market Cap: $362.8 million Price-to-Book: N/AGarrett Motion (NYSE:GTX) makes turbochargers for light and commercial vehicles. Until October 2018, it was part of Honeywell (NYSE:HON), when it was spun-off from the industrial conglomerate. Honeywell shareholders got one share in Garrett for every $10 shares in the parent.How have shareholders made out? With dividends, they've probably broken even, but that's about it. Trading slightly below $5 as I write this, it traded as high as $20 in April 2019. On May 11, Garrett reported its Q1 2020 results. Sales fell by 8.5%, excluding currency, to $745 million, while its adjusted net income declined by 26% to $68 million. However, both its top- and bottom-line handily beat analyst estimates for the quarter.During the company's conference call May 11, CEO Olivier Rabiller stressed that despite its fastest-growing plant shutting down for six weeks during the first quarter -- it's in Wuhan, the epicenter of the global pandemic -- it has fared better than many others operating in the global automotive sector and that speaks to Garrett's global capabilities. Down 52% on the year, Garrett could be the best buy of the bunch. Information Services Group (III)Market Cap: $86.2 million Price-to-Book: 0.99The smallest of the penny stocks to buy, good things come in small packages. Information Services Group (NASDAQ:III) is a technology consulting firm that helps more than 700 clients transform their businesses through digitalization. It consults for 75 of the world's top 100 enterprises. It's a big deal despite its size.Over the past year, III stock has drifted down from $3 in July 2019, to $1.80 as I write this, down 30% on the year. What has been the problem? It's hard to put my finger on it. The company does have operating expenses that are higher than the revenue it brings in but on an adjusted basis it does make money. In the first quarter, it reported revenue of $63.7 million, flat to last year, excluding currency. In terms of the bottom line, its adjusted profit in Q1 2020 was $1.1 million, down 26.7% from the same period a year earlier. The good news is that CEO Michael Connors believes that it will double its profitability in the second quarter compared to the first, despite the demand for its advisory services slowing due to Covid-19. I wouldn't bet the farm, but an increase in profits could result in a tangible jump in its stock price over the next three to six months. * 10 of the Best Long-Term Stocks to Buy When the Market's Down To recap, the ten penny stocks that make the list are as follows: * Banco Bbva Argentina * Global Cord Blood * Silvercorp Metals * Newmark Group * Smith Micro Software * Orion Energy Systems * Mistras Group * Office Depot * Garrett Motion * Information Services GroupWill Ashworth has written about investments full-time since 2008. Publications where he's appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia. At the time of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * Top Stock Picker Reveals His Next 1,000% Winner * The Huge Story for 2020 & Beyond That You Aren't Hearing About * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * The 1 Stock All Retirees Must Own The post 10 Penny Stocks to Buy Under $5 That Might Be Worth the Risk appeared first on InvestorPlace.

  • PR Newswire

    Global Cord Blood Corporation Provides Further Update on COVID-19

    Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 novel coronavirus ("COVID-19") on the Company's expected fiscal 2021 operations.

  • Those Who Purchased Herc Holdings (NYSE:HRI) Shares Three Years Ago Have A 56% Loss To Show For It
    Simply Wall St.

    Those Who Purchased Herc Holdings (NYSE:HRI) Shares Three Years Ago Have A 56% Loss To Show For It

    Herc Holdings Inc. (NYSE:HRI) shareholders will doubtless be very grateful to see the share price up 55% in the last...

  • Thomson Reuters StreetEvents

    Edited Transcript of CO earnings conference call or presentation 12-Mar-20 12:00pm GMT

    Q3 2020 Global Cord Blood Corp Earnings Call

  • 3 Medical Companies With the Strength to Weather Coronavirus Fears
    GuruFocus.com

    3 Medical Companies With the Strength to Weather Coronavirus Fears

    Stocks to consider as stimulus bill fails and CVS accelerates labor demand Continue reading...

  • PR Newswire

    Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020

    Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of fiscal year 2020 ended December 31, 2019.

  • Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results
    PR Newswire

    Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results

    Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial results for the third quarter and first nine months of fiscal year 2020 on Wednesday, March 11, 2020, after the market close.

  • PR Newswire

    Global Cord Blood Corporation Provides Update on Impact of Coronavirus

    Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 novel coronavirus ("2019-nCoV") on its operations.

  • Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
    PR Newswire

    Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

    Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr. Siu Chuen Cheng as a new independent non-executive director to the Board of Directors of the Company (the "Board").

  • Thomson Reuters StreetEvents

    Edited Transcript of CO earnings conference call or presentation 27-Nov-19 1:00pm GMT

    Q2 2020 Global Cord Blood Corp Earnings Call

  • Hedge Funds Have Never Been More Bullish On Global Cord Blood Corporation (CO)
    Insider Monkey

    Hedge Funds Have Never Been More Bullish On Global Cord Blood Corporation (CO)

    Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The last 12 months is one of those periods, as the Russell 2000 […]

  • PR Newswire

    PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided

    Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported that China's National Health Commission ("NHC") recently issued a new policy allowing the relevant Provincial Health Commissions ("PHCs") to approve cord blood bank licenses in 18 pilot Free Trade Zones ("FTZs") in China.

  • PR Newswire

    Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting

    Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual General Meeting, which was held on December 5, 2019, in Hong Kong S.A.R., China.

  • PR Newswire

    Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on November 27, 2019 HONG KONG , Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...

  • PR Newswire

    Global Cord Blood Corp Comments on New Regulation

    HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in possession of human DNA information relating to the PRC. The Company is still in the process of evaluating the implications of the new regulation on the cord blood banking industry and its business. The Regulation of the People's Republic of China on the Administration of Human Genetic Resources (the "Regulation") has come into effect and the Company recently received an inquiry concerning its impact on the Company.

  • PR Newswire

    Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director

    HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independent non-executive director to the Board of Directors of the Company (the "Board"). In order to further strengthen GCBC's Board composition and the Company's leadership position in China's evolving cord blood banking industry, the Board is delighted to announce that Mr. Jack Chow will join the Board as a class B independent non-executive director, effective immediately.

  • Were Hedge Funds Right About Warming Up To Global Cord Blood Corp (CO)?
    Insider Monkey

    Were Hedge Funds Right About Warming Up To Global Cord Blood Corp (CO)?

    Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the first […]

  • PR Newswire

    The Committee for China Cord Fairness Announces Support From The Two Leading Proxy Advisory Firms for Proposals Seeking Minority Shareholder Protections and Governance Enhancements at Global Cord Blood Corporation

    Both ISS and Glass Lewis Support Conditioning All Business Transactions on Approval by a Majority of the Unaffiliated Shareholders ISS Notes "A number of governance shortcomings have been identified" ...

  • PR Newswire

    Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019

    HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2019 annual general meeting of shareholders at its Hong Kong office located at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 5, 2019 (8:00 a.m. U.S. Eastern Standard Time on December 5, 2019).

  • Thomson Reuters StreetEvents

    Edited Transcript of CO earnings conference call or presentation 28-Aug-19 12:00pm GMT

    Q1 2020 Global Cord Blood Corp Earnings Call

  • ACCESSWIRE

    Global Cord Blood Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Global Cord Blood Corp. (NYSE: CO ) will be discussing their earnings results in their 2020 First Quarter Earnings to be held on August 28, 2019 at 8:00 AM ...

  • PR Newswire

    Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020

    1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ( $39.8 Million )                                   Gross Profit Up 19.4% YoY to RMB227.6 million ( $33.2 million ) Operating ...

  • PR Newswire

    Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results

    The Company will host a conference call at 8:00 a.m. ET on Wednesday, August 28, 2019 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties can access the audio webcast through the Company's IR website at http://ir.globalcordbloodcorp.com. A replay of the webcast will be accessible two hours after the conference call and available for 7 days at the same URL as above.

  • PR Newswire

    Global Cord Blood Corporation (NYSE: CO) Urged To Explain Management Compensation in Third Letter From Shareholder Group

    NEW YORK, Aug. 7, 2019 /PRNewswire/ -- The Seiden Group, a law firm headquartered in New York, representing a shareholder group of Global Cord Blood Corporation (NYSE: CO) (the "Company" or "Global Cord") issued a third letter yesterday to Global Cord, which was addressed to the Compensation Committee of the Board of Directors. In the letter, the shareholder group also urged the Compensation Committee to fulfill its obligation to the Company and its shareholders, as described in its most recent 20-F filed with the SEC, to replace the underperforming executives who have not created shareholder value over the past ten years and hire a new team to lead the Company.

  • PR Newswire

    Global Cord Blood Corporation Files Its Annual Report on Form 20-F

    HONG KONG , July 24, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, ...